Scholars Central

Mini reviewPublished 28 Mar 2023

Pathophysiology, biomarkers, and therapies for asthma Endotypes: Exploring the Immunology of Asthma.

Authors: Marvin Varsh

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

In children and adults, asthma is a frequent condition that has a high morbidity, mortality, and economic cost. Asthma is generally acknowledged as a diverse disease, and recent advances in clinical and laboratory studies have clarified our understanding of the immunology that underlies the condition. The future of asthma is endotype classification, which links observable traits with immunological processes. This in-depth analysis of the immunology of asthma covers the pathophysiology currently understood, clinical practise biomarkers, as well as cutting-edge biologic and tailored treatments for all asthma endotypes. Understanding the immunology of asthma will help medical professionals classify individuals according to their endotype and offer individualised, biomarker-driven therapy to efficiently control their asthma.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical Pathology and Laboratory Medicine.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical Pathology and Laboratory Medicine
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Marvin Varsh”